Sign in
Taking people in FrancePhase 2

Testing cholestyramine to lower pollutant levels in women with obesity

Tests cholestyramine on pollutant levels in women aged 18 to 64 with obesity.

Key facts

Who runs it
Centre Hospitalier Universitaire De Nice
Where
Nice, FranceSee the site
Registry title
Exploratory evaluation of the effect of cholestyramine on serum levels of persistent organic pollutants in obese patients
Status
Recruiting
Phase
Phase 2
People taking part
40 people, planned
Started
8 Feb 2024
Planned end
1 Jun 2025
Type of study
Interventional
Record updated
27 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with obesity who are planning bariatric surgery. It studies whether cholestyramine lowers pollutant levels in the blood.

Age
18 to 45 years (the inclusion criteria); the record's age fields say 18 Years to 64 Years.
Sex
Women only.
Disease stage
Obesity with an accepted reason for bariatric surgery: BMI > 40 kg/m2, or BMI > 35 kg/m2 with complication(s) that surgery can improve.
Earlier treatment
Cannot be taking anti-vitamin K, digoxin or levothyroxine, or likely to take them within 3 months of joining.

Main reasons for not taking part

  • Pregnant or breastfeeding women
  • Known allergy or intolerance to cholestyramine
  • Chronic constipation
  • Phenylketonuria
  • Chronic disease that may affect the treatment, such as unbalanced diabetes with HbA1c >7% (53 mmol/mol), known and treated dyslipidaemia, chronic renal failure with GFR <60 ml/min, or hepatocellular failure

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Female patients with an accepted indication for bariatric surgery (BMI > 40 kg/m2 or BMI > 35 kg/m2 with complication(s) improveable by surgery)
  • Aged between 18 and 45 years
  • Having effective contraception (according to Recommendations related to contraception and pregnancy testing in clinical trials Version 1.2 (CTCG Clinical Trials Coordination Group))

Who cannot take part

  • Patients on anti-vitamin K, digoxin, levothyroxine or likely to be on such therapy within 3 months of inclusion
  • Known allergy or intolerance to cholestyramine
  • Chronic disease that may interfere with the efficacy of treatment (unbalanced diabetes with HbA1c >7%, known and treated dyslipidaemia, chronic renal failure with GFR <60 ml/min, hepatocellular failure)
  • Pregnant or breastfeeding women
  • Chronic constipation
  • Phenylketonuria

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in France

  • Centre Hospitalier Universitaire de NiceNice, FranceTaking people

About the trial

What the trial wants to find out

To evaluate the effect of cholestyramine treatment on serum concentrations of different persistent organic pollutants in a population of obese women of childbearing age for whom bariatric surgery is indicated

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Exploratory evaluation of the effect of cholestyramine on serum levels of persistent organic pollutants in obese patients
Plain-language title
Testing cholestyramine to lower pollutant levels in women with obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2023-505116-37-00, who can take part
Record updated
27 April 2026